Industry News
Pharmaceutical Industry News
After being pushed by attorneys…
After being pushed by attorneys general from 22 states, U.S. healthcare leaders are taking another look at the circumstances under which mifepristone can be prescribed.
Guardant Health is joining in on…
Guardant Health is joining in on the American Lung Association’s push to raise awareness about lung cancer screening and biomarker testing.
Moderna has opened the doors to…
Moderna has opened the doors to its long-anticipated Harwell vaccine production facility in the U.K. The facility debut comes as Moderna's competitors take shots at British life sciences policies and retreat from previously planned projects
Un decano de Harvard cobró 150.000 dólares como perito en las demandas contra Tylenol
El gobierno de Trump ha citado la pericia de Andrea Baccarelli para advertir contra el uso del paracetamol —el principio activo del Tylenol— en el embarazo, basándose en una relación no demostrada con el autismo.
Soleno Therapeutics is breathing…
Soleno Therapeutics is breathing easier with a report from Acadia Pharmaceuticals that its candidate to treat hyperphagia in patients with Prader-Willi Syndrome has come up short in a phase 3 trial and has been scrapped
The vast majority of drugmakers…
The vast majority of drugmakers are either considering or have already established direct-to-patient programs, cutting out middlemen to offer services like virtual care consultations, payment support, at-home diagnostics and digital pharmacies.
Excitement around Fujifilm…
Excitement around Fujifilm Biotechnologies’ massive new cell culture facility in Holly Springs, North Carolina, has been growing steadily since 2021, prompting a beefed-up investment from the company last April and a string of high-profile manufacturing
As drugmakers are turning away…
As drugmakers are turning away from England, Eli Lilly CEO David Ricks has joined the chorus, calling it “probably the worst country in Europe” for drug pricing and adding that England is “not an attractive environment
Indian generics makers have inked…
Indian generics makers have inked partnerships with the Gates Foundation, the Clinton Health Access Initiative and other groups to help roll out cheaper versions of Gilead's Yeztugo in certain low- and middle-income countries.
Hengrui Pharma’s dealmaking…
Hengrui Pharma’s dealmaking spree rolls on, with a potential $1.1 billion transaction on a rival to AstraZeneca and Daiichi Sankyo’s blockbuster Enhertu being the latest addition.
The FDA has handed Biogen a…
The FDA has handed Biogen a complete response letter requesting that the company update “technical information” included in the chemistry, manufacturing and controls portion of its filing for high-dose Spinraza. Biogen said it aims to
The Billionaire, the Psychedelics and the Best-Selling Memoir
Amy Griffin wrote a book based on recovered memories of childhood sexual abuse. Oprah Winfrey and a slew of celebrities promoted it. Then questions arose.
Vertex has begun a full-court…
Vertex has begun a full-court press for Journavx, enlisting NBA All-Star Jayson Tatum to discuss his use of the new non-opioid painkiller while recovering from a serious injury.
F.D.A.’s Approval of a Drug for Autism Upends Review Process
The agency expanded use of an old drug as a treatment for some people with autism. The endorsement sent some customers scrambling to buy over-the-counter supplements with the same ingredients.
Harvard Dean Was Paid $150,000 as an Expert Witness in Tylenol Lawsuits
The Trump administration has cited Dr. Andrea Baccarelli’s expertise to warn against using acetaminophen — the active ingredient in Tylenol — in pregnancy, based on an unproven autism link.
4 Autism Experts React to Trump’s Plan
This is not what people with autism need, experts say.
Although more than half of Gen Z…
Although more than half of Gen Z survey respondents turn to doctors and experts for health advice, 38% also value social media as a trusted source, compared to 22% among other, older generations.
In a recent warning letter, the…
In a recent warning letter, the FDA chastised Janssen Vaccines for inconsistent quality control procedures and failure to follow up thoroughly on product complaints—issues that came to light during an inspection of the Johnson &
Public health experts and doctors…
Public health experts and doctors say the ACIP's chaotic voting process and changes to vaccine recommendations will sow confusion and doubt among patients and parents.
PatientView surveyed a total of…
PatientView surveyed a total of 518 patient groups representing dozens of rare diseases. Their responses detail their views of 32 pharmas and the industry at large in 2024.